CareDx Announces Presentation of More Than 50 Abstracts Including 16 Oral Presentations at the International Society for Heart and Lung Transplantation’s 46th …

The Transplant Company™, a leading precision medicine company focused on the discovery, development, and commercialization of ...
Reuters

Fact Check: Research abstract is not reliable evidence of a link between mRNA vaccines and heart disease

A research abstract cited by commentators as proof that COVID-19 vaccines increase a person’s risk of heart disease has raised multiple concerns from experts. The 319-word abstract, published in the ...
Nasdaq

Tenaya Therapeutics to Present Five Abstracts on Innovative Heart Disease Gene Therapies at ASGCT 2025 Annual Meeting

Tenaya Therapeutics, Inc. announced that it will present five abstracts at the American Society of Gene and Cell Therapy's 28th Annual Meeting from May 13-17, 2025, in New Orleans. The presentations ...
The American Journal of Managed Care

Abstracts Outline Costs of Heart Health in US, Benefits of Protective Measures

New research presented at the American College of Cardiology's 71st Annual Scientific Session & Expo highlights the high costs of heart failure in the United States and the benefits of healthy eating ...
Seeking Alpha

BioCardia Announces Two Scientific Abstracts Have Been Accepted at the 2024 Technology and Heart Failure Therapeutics Conference

SUNNYVALE, Calif., Jan. 31, 2024 (GLOBE NEWSWIRE) -- BioCardia, Inc. (BCDA) (“BioCardia” or the “Company”) (Nasdaq: BCDA), a biotechnology company focused on ...
Seeking Alpha

CareDx Announces Presentation of 60 Abstracts Including 19 Oral Presentations at the 2025 International Society for Heart and Lung Transplantation Meeting

Breadth of Data Demonstrates Growing Real-World Adoption and Clinical Importance of CareDx Testing Solutions in Heart and Lung Transplant Patient Management New SHORE Study Findings Demonstrate that ...